• Tech Coast Angels reported a profitable exit from Atraverse Medical following its acquisition by Johnson & Johnson.
• Exit delivered over a 70% IRR in under three years, exceeding typical early-stage medtech venture return targets.
• Atraverse develops an RF guidewire used to access the left heart chamber during minimally invasive procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tech Coast Angels Inc published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.